Comparison of prior authorization and prospective audit with feedback for antimicrobial stewardship

Infection Control and Hospital Epidemiology

Volumn 35, Issue 9, 2014, Pages 1092-1099

  Mehta, Jimish M ^a   Haynes, Kevin ^a   Paul Wileyto, E ^a   Gerber, Jeffrey S ^b   Timko, Daniel R ^c   Morgan, Steven C ^c   Binkley, Shawn ^c   Fishman, Neil O ^d   Lautenbach, Ebbing ^a,d   Zaoutis, Theoklis ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; AZTREONAM; CEFEPIME; CEFTAZIDIME; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANTIMICROBIAL STEWARDSHIP PROGRAM; ANTIMICROBIAL THERAPY; ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; HEALTH CARE POLICY; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MORTALITY; OUTCOME ASSESSMENT; PRESCRIPTIVE AUTHORITY; PRIOR AUTHORIZATION POLICY; PROSPECTIVE STUDY; QUASI EXPERIMENTAL STUDY; ADAPTIVE BEHAVIOR; ADOLESCENT; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; INAPPROPRIATE PRESCRIBING; MIDDLE AGED; PREVENTION AND CONTROL; PROGRAM EVALUATION; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UNITED STATES; UNIVERSITY HOSPITAL; VERY ELDERLY; YOUNG ADULT;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DRUG UTILIZATION REVIEW; FEEDBACK, PSYCHOLOGICAL; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; LENGTH OF STAY; MALE; MEDICAL AUDIT; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PENNSYLVANIA; PROGRAM EVALUATION; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84905967311     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/677624     Document Type: Article

References (24)

1. Fishman N. Antimicrobial stewardship. Am J Med 2006;119(6 suppl 1):S53-S61. doi:10.1016/j.amjmed.2006.04.003.
2. Dellit TH, Owens RC, McGowan JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44(2): 159-177. doi:10.1086/510393.
3. Drew RH, White R, MacDougall C, Hermsen ED, Owens RC; Society of Infectious Diseases Pharmacists. Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Pharmacotherapy 2009;29(5):593-607. doi:10.1592/phco.29.5.593.
4. Fraser GL, Stogsdill P, Dickens JD, Wennberg DE, Smith RP, Prato BS. Antibiotic optimization: an evaluation of patient safety and economic outcomes. Arch Intern Med 1997;157(15):1689-1694.
5. Solomon DH, Van Houten L, Glynn RJ, et al. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med 2001;161(15):1897-1902.
6. Carling P, Fung T, Killion A, Terrin N, Barza M. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 2003; 24(9):699-706. doi:10.1086/502278.
7. Elligsen M, Walker SAN, Pinto R, et al. Audit and feedback to reduce broad-spectrum antibiotic use among intensive care unit patients: a controlled interrupted time series analysis. Infect Control Hosp Epidemiol 2012;33(4):354-361. doi:10.1086/664757.
8. Woodward RS, Medoff G, Smith MD, Gray JL. Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital. Am J Med 1987;83(5): 817-823.
9. White AC, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997;25(2):230-239.
10. Research Committee of the Society of Healthcare Epidemiology of America. Enhancing patient safety by reducing healthcareassociated infections: the role of discovery and dissemination. Infect Control Hosp Epidemiol 2010;31(2):118-123. doi:10.1086 /650198.
11. Society for Healthcare Epidemiology of America, Infectious Diseases Society of America, Pediatric Infectious Diseases Society. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol 2012; 33(4):322-327. doi:10.1086/665010.
12. McGowan JE. Antimicrobial stewardship-the state of the art in 2011: focus on outcome and methods. Infect Control Hosp Epidemiol 2012;33(4):331-337. doi:10.1086/664755.
13. Gross R, Morgan AS, Kinky DE, Weiner M, Gibson GA, Fishman NO. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis 2001; 33(3):289-295. doi:10.1086/321880.
14. Morris AM, Brener S, Dresser L, et al. Use of a structured panel process to define quality metrics for antimicrobial stewardship programs. Infect Control Hosp Epidemiol 2012;33(5):500-506. doi:10.1086/665324.
15. Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 2007;44(5):664-670. doi:10.1086/511640.
16. Polk RE, Hohmann SF, Medvedev S, Ibrahim O. Benchmarking risk-adjusted adult antibacterial drug use in 70 US academic medical center hospitals. Clin Infect Dis 2011;53(11):1100-1110. doi:10.1093/cid/cir672.
17. Cook TD, Campbell DT. Quasi-Experimentation. Boston: Houghton Mifflin, 1979.
18. Harris AD, Bradham DD, Baumgarten M, Zuckerman IH, Fink JC, Perencevich EN. The use and interpretation of quasiexperimental studies in infectious diseases. Clin Infect Dis 2004; 38(11):1586-1591. doi:10.1086/420936.
19. Shardell M, Harris AD, El-Kamary SS, Furuno JP, Miller RR, Perencevich EN. Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clin Infect Dis 2007;45(7):901-907. doi:10.1086/521255.
20. Engle RF. Autoregressive conditional heteroscedasticity with estimates of the variance of United Kingdom inflation. Econometrica 1982;50(4):987-1007.
21. Bera AK, Higgins ML. ARCH models: properties, estimation and testing. J Econ Surv 1993;7(4):305-366.
22. Cosgrove SE, Seo SK, Bolon MK, et al. Evaluation of postprescription review and feedback as a method of promoting rational antimicrobial use: a multicenter intervention. Infect Control Hosp Epidemiol 2012;33(4):374-380. doi:10.1086/664771.
23. Stevenson KB, Balada-Llasat J-M, Bauer K, et al. The economics of antimicrobial stewardship: the current state of the art and applying the business case model. Infect Control Hosp Epidemiol 2012;33(4):389-397. doi:10.1086/664910.
24. Gentry CA, Greenfield RA, Slater LN, Wack M, Huycke MM. Outcomes of an antimicrobial control program in a teaching hospital. Am J Health Syst Pharm 2000;57(3):268-274.